19A Application for information on Central Register—prescribed explanatory material
For the purposes of section 56(4) of the Act, the following information is prescribed explanatory material—
(a) information about the requirements of Part 6 of the Act in relation to the disclosure of identifying information from the Central Register;
(b) information about the lodgement of a contact preference by or on behalf of a person whose identifying information is to be disclosed, including any possible consequences for the applicant;
(c) information about the requirements of Part 6 of the Act in relation to compliance with a contact preference lodged by a person whose identifying information is to be disclosed;
(d) information about the issues which may arise if the applicant intends to contact a person whose identifying information is to be disclosed;
(e) information about possible consequences for the applicant if the person whose identifying information is to be disclosed cannot be located or is deceased;
(f) if the applicant is a donor, information about possible consequences for the person, whose identifying information is to be disclosed, only becoming aware that the person was born as a result of a donor treatment procedure, as a consequence of the application being made;
(g) if the applicant is a parent of a person born as a result of a donor treatment procedure, information about—
(i) advising the applicant's child of the child's donor origins; and
(iii) the significance to the applicant's child of a biological connection with the donor and the benefits of early disclosure and early connection with any donor siblings; and
(iv) how to support the applicant's child with the child's sense of identity; and
(v) any safety or privacy issues for the applicant's child that may arise if contact is established with the donor; and
(vi) any issues that may arise if the applicant's child makes contact with donor siblings who are raised in different families;
Donor siblings raised in different families according to different beliefs and values or in different geographic locations.
(h) if the person whose identifying information is to be disclosed is a donor, information about possible consequences of the donor becoming aware as a consequence of the application being made that a person was born as a result of a donor treatment procedure carried out using the donor's gametes;
(i) information about any other adverse consequence of disclosing identifying information from the Central Register;
If the applicant is a person born as a result of a donor treatment procedure or a parent or guardian of a person born as a result of a donor treatment procedure, information about the possibility that the donor might regret they have donated.
(j) information about the possibility that an applicant's family may not agree with the applicant's plans in relation to making contact;
(k) information about counselling services available to the applicant;
(l) information about mental health support and intervention services that can provide crisis support and any other support services that might be relevant to the applicant;
(m) information about the Donor Conception Registrar's reasons for providing the explanatory material to the applicant;
(n) information about the benefits to the applicant of considering the explanatory material before the applicant proceeds with an application under section 56 of the Act;
(o) information about how to approach discussions about genetic and medical issues and possible outcomes of those discussions;
(p) if the applicant is a donor, information about the possibility that the applicant may be contacted to request information about the applicant's health and medical history, including any hereditary conditions.
Reg. 20 substituted by S.R. No. 141/2024 reg. 16.
20 Notice of intended disclosure to a person (other than a pre-1998 donor or a person born as a result of a donor treatment procedure)—prescribed explanatory material
For the purposes of section 62(1) of the Act, the following information is prescribed explanatory material—
(a) information about the requirements of Part 6 of the Act in relation to the disclosure of identifying information from the Central Register;
(b) information about possible consequences for the person whose identifying information is to be disclosed if that identifying information is disclosed from the Central Register;
(c) information about the issues which may arise if the applicant intends to contact the person whose identifying information is to be disclosed;
(d) information about mental health support and intervention services that can provide crisis support and any other support services that might be relevant to the person whose identifying information is to be disclosed;
(e) information about counselling services available to the person whose identifying information is to be disclosed;
(f) information about the issues which may arise for the person whose identifying information is to be disclosed if the person is contacted by another person following the disclosure of the person's identifying information from the Central Register;
Information about risks to the safety or privacy of the person whose identifying information is to be disclosed.
(g) information about the Donor Conception Registrar's reasons for providing the explanatory material to the person whose identifying information is to be disclosed;
(h) information about the benefits to the person whose identifying information is to be disclosed of considering the explanatory material;
(i) information about the possibility that the person whose identifying information is to be disclosed may be contacted to request information about the health and medical history of the person whose identifying information is to be disclosed, including any hereditary conditions.
Reg. 20A inserted by S.R. No. 141/2024 reg. 16.
20A Notice of intended disclosure to person born as a result of a donor treatment procedure or a pre-1998 donor—prescribed explanatory material
For the purposes of section 62(4) of the Act, the following information is prescribed explanatory material—
(c) information about possible consequences for the pre-1998 donor, the person born as a result of a donor treatment procedure or, if the person born as a result of a donor treatment procedure is a child, the person's parent or guardian, if a contact preference is lodged;
(d) information about possible consequences for the pre-1998 donor, the person born as a result of a donor treatment procedure or, if the person born as a result of a donor treatment procedure is a child, the person's parent or guardian, if a contact preference is not lodged;
(e) information about the requirements of Part 6 of the Act in relation to the disclosure of identifying information from the Central Register;
(f) information about mental health support and intervention services that can provide crisis support and any other support services that might be relevant to the pre-1998 donor, the person born as a result of a donor treatment procedure or, if the person born as a result of a donor treatment procedure is a child, the person's parent or guardian;
(g) information about counselling services available to the pre-1998 donor, the person born as a result of a donor treatment procedure or, if the person born as a result of a donor treatment procedure is a child, the person's parent or guardian;
(h) information about the possibility that the pre‑1998 donor, the person born as a result of a donor treatment procedure or, if the person born as a result of a donor treatment procedure is a child, the person's parent or guardian, may be contacted by another person following the disclosure of identifying information from the Central Register and any issues that may arise from that contact;
Information about risks to the safety or privacy of the pre-1998 donor, the person born as a result of a donor treatment procedure or, if the person is a child, the person's parent or guardian.
(i) information about the Donor Conception Registrar's reasons for providing the explanatory material to the pre-1998 donor, the person born as a result of a donor treatment procedure or, if the person born as a result of a donor treatment procedure is a child, the person's parent or guardian;
(j) information about the benefits to the pre-1998 donor, the person born as a result of a donor treatment procedure or, if the person born as a result of a donor treatment procedure is a child, the person's parent or guardian of considering the explanatory material;
(k) if the identifying information to be disclosed relates to a pre-1998 donor, information about the possibility that the pre-1998 donor may be contacted to request information about the pre-1998 donor's health and medical history, including any hereditary conditions;
(l) if the identifying information to be disclosed relates to a person born as a result of a donor treatment procedure who is a child, information about—
(iii) the significance to the child of a biological connection with the donor and the benefits of early disclosure and early connection with any donor siblings; and
(vi) any issues that may arise for the child if contact is made with donor siblings who are raised in different families.